Aegis FinanceAegis Finance

Opportunity Explorer

Every list the engine produced, in one sortable table: who the company is, how much it is held, where the price sits against the analysts, why it was picked and by which service, what is coming, and what insiders are doing. Click a row for the reasons, the news and the filings.

MoveScore (magnitude)

How far the stock may move over the next 21 trading sessions, up or down, from its own recent volatility. It says how big, never which way.

positive Analyst stance

What analysts say: their consensus rating plus whether targets were raised or cut over 90 days. It is not a forecast, and it can sit beside a negative upside. Upside has its own column: grey and "LOW UPSIDE" below +5%, never green from one target.

High-Risk Innovation

Three separate checks: thin coverage (fewer than 3 firms with a dated target in 180 days), a binary FDA/trial event within 63 weekdays, and short cash runway (under 4 quarters of operating loss). The badge needs 2 of the 3; a single flag is printed under the ticker.

FDA words: CRL = FDA Complete Response Letter · PDUFA = PDUFA date · BLA = Biologics License Application · NDA = New Drug Application · sNDA = Supplemental NDA